SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-023004
Filing Date
2024-04-29
Accepted
2024-04-29 16:28:49
Documents
21
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20024296x2_def14a.htm DEF 14A 1017212
2 logo_ocuphire.jpg GRAPHIC 33979
3 ny20024296x2_cgallagher.jpg GRAPHIC 35478
4 ny20024296x2_five.jpg GRAPHIC 7044
5 ny20024296x2_four.jpg GRAPHIC 6942
6 ny20024296x2_gmagrath.jpg GRAPHIC 36563
7 ny20024296x2_jpepose.jpg GRAPHIC 35781
8 ny20024296x2_jsmanuso.jpg GRAPHIC 35113
9 ny20024296x2_one.jpg GRAPHIC 6802
10 ny20024296x2_pc02.jpg GRAPHIC 774656
11 ny20024296x2_pvp01.jpg GRAPHIC 156588
12 ny20024296x2_pvp02.jpg GRAPHIC 164931
13 ny20024296x2_rrodgers.jpg GRAPHIC 35521
14 ny20024296x2_sainsworth.jpg GRAPHIC 34832
15 ny20024296x2_six.jpg GRAPHIC 7111
16 ny20024296x2_skbenton.jpg GRAPHIC 35974
17 ny20024296x2_three.jpg GRAPHIC 7210
18 ny20024296x2_two.jpg GRAPHIC 7067
19 ny20024296x2_pc01x1.jpg GRAPHIC 647327
20 sig_georgemagrath.jpg GRAPHIC 12855
21 sig_georgemagrathx1.jpg GRAPHIC 8879
  Complete submission text file 0001140361-24-023004.txt   3894541
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34079 | Film No.: 24891390
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)